The current $195 million investment is part of a commitment to invest more than $10 billion for innovation and manufacturing capacity enhancement.

An oxygen-generating implant keeps high-density insulin-producing cells alive in diabetic rats for months without immune suppression.

Model serves as platform for understanding how chronic inflammation related to alcohol consumption accelerates pancreatic cancer development.

AIs are as much a tool as a hammer or shovel, but to find the opportunities, we need to understand what the realities and risks are.

Bayer will partner with Kumquat Biosciences to develop Kumquat’s KRAS G12D inhibitor, which could generate $1.3 billion-plus for the San Diego biotech.

The basal ganglia in rats uses separate codes for learned movements and “natural” behaviors, offering insights into human ...

Knocking down EPIC1 sensitized triple negative breast tumor-bearing mice to immunotherapy with the PD-1 inhibitor pembrolizumab.

Sarepta Therapeutics said Friday that the deaths of two patients taking its marketed gene therapy Elevidys® (delandistrogene ...

The enhanced hybrid model improves the predictive capability of data-driven modeling and reduces the need for process knowledge.

Surging demand for vectors has also prompted suppliers to explore novel transfection technologies—including electroporation or transposon-based systems—to improve yield. Traditional methods rely on ...

In search of a better approach to designing and developing these small proteins, researchers turned to ProtGPT2.

The AI tool, named “Pythia,” predicts how cells repair their DNA after CRISPR editing and opens the door to next-generation gene therapies.